Cargando…
Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial
IMPORTANCE: Intense interest exists in novel ω-3 formulations with high bioavailability to reduce blood triglyceride (TG) levels. OBJECTIVE: To determine the phase 3 efficacy and safety of a naturally derived krill oil with eicosapentaenoic acid and docosahexaenoic acid as both phospholipid esters (...
Autores principales: | Mozaffarian, Dariush, Maki, Kevin C., Bays, Harold E., Aguilera, Fernando, Gould, Glenn, Hegele, Robert A., Moriarty, Patrick M., Robinson, Jennifer G., Shi, Peilin, Tur, Josefina F., Lapointe, Jean-François, Aziz, Sarya, Lemieux, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739762/ https://www.ncbi.nlm.nih.gov/pubmed/34989797 http://dx.doi.org/10.1001/jamanetworkopen.2021.41898 |
Ejemplares similares
-
Prescription ω−3 Therapy to Reduce Triglyceride Levels—A New Horizon for Cost-effective Therapy
por: Mozaffarian, Dariush
Publicado: (2022) -
Hypertriglyceridemia
por: Brahm, Amanda, et al.
Publicado: (2013) -
Genetics of Hypertriglyceridemia
por: Dron, Jacqueline S., et al.
Publicado: (2020) -
Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia
por: Hang, Shyann M.T., et al.
Publicado: (2023) -
SUN-593 Variants in Known Monogenic Causal Genes of Hypertriglyceridemia Are Not Major Contributors for Hypertriglyceridemia in Lipodystrophy Due to a LMNA Mutation
por: Ueda, Masako, et al.
Publicado: (2020)